Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by ...
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback